financetom
Business
financetom
/
Business
/
Startup Rivos raises $250 million to develop RISC-V AI chips
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Startup Rivos raises $250 million to develop RISC-V AI chips
Apr 16, 2024 6:44 AM

(Reuters) - Chip startup Rivos said on Tuesday it raised $250 million in a funding round that will enable it to manufacture its first server chip geared for artificial intelligence.

Nvidia's ( NVDA ) combination of chips and CUDA software dominates the market for AI-related computing, and Nvidia ( NVDA ) gobbled up more than 80% market share of AI chips in 2023. But a host of startups and chip giants have started to launch competing products, such as Intel's ( INTC ) Gaudi 3 and Meta's inference chip - both unveiled last week.

Rivos is tight-lipped about the specifics of the product, but has disclosed that its plans include designing chips based on the RISC-V architecture, which is an open source alternative to the architectures made by Arm, Intel ( INTC ) and Advanced Micro Devices ( AMD ). Instruction set architectures such as RISC-V are the building blocks of semiconductor designs, and using the open source alternative means Rivos does not have to pay a license fee to Arm.

"RISC-V doesn't have a (large) software ecosystem, so I decided to form a company and then build software-defined hardware - just like what CUDA did with Nvidia ( NVDA )," said Lip-Bu Tan, founding managing partner at Walden Catalyst, one of Rivos' investors.

Santa Clara, California-based Rivos is in the process of designing a server chip that combines a central processing unit and AI accelerator component that will be optimized for large language models and data analytics. The company began with the software necessary to compile computer code to allow the chip to run a program and designed the processor around the software.

"Usually the chip companies do it the other way: build the silicon, and then build the software on top," CEO Puneet Kumar told Reuters in an interview. "We decided, as a company that we should first look at software."

Matrix Capital Management was the largest investor in the funding round that also included investments from Intel ( INTC ), MediaTek ( MDTTF ) and Dell Technologies ( DELL ).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Berkshire Hathaway director Olson to step down, Buffett opposes shareholder proposals
Berkshire Hathaway director Olson to step down, Buffett opposes shareholder proposals
Mar 14, 2025
March 14 (Reuters) - Berkshire Hathaway ( BRK/A ) said on Friday longtime Director Ronald Olson will be leaving its board because of a policy change requiring directors, except for Warren Buffett, to step down after turning 80. In a proxy statement for its May 3 annual meeting in Omaha, Nebraska, Berkshire also said its board unanimously urged the rejection...
Baldwin Insurance Group Insider Sold Shares Worth $5,444,677, According to a Recent SEC Filing
Baldwin Insurance Group Insider Sold Shares Worth $5,444,677, According to a Recent SEC Filing
Mar 14, 2025
06:03 PM EDT, 03/14/2025 (MT Newswires) -- Trevor Baldwin, Director, Chief Executive Officer, Member of 10% Owner Group, on March 12, 2025, sold 136,101 shares in Baldwin Insurance Group ( BWIN ) for $5,444,677. Following the Form 4 filing with the SEC, Baldwin has control over a total of 40,978 Class A common shares of the company, with 13,302 shares...
Drugmakers agree to participate in second round of price negotiations
Drugmakers agree to participate in second round of price negotiations
Mar 14, 2025
(Reuters) - All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second round of price talks have agreed to participate in the negotiation process, a federal health agency said on Friday. (Reporting by Bhanvi Satija and Sneha SK in Bengaluru) ...
Drugmakers agree to participate in second round of price negotiations
Drugmakers agree to participate in second round of price negotiations
Mar 14, 2025
March 14 (Reuters) - All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second round of price talks have agreed to participate in the negotiation process, a federal health agency said on Friday. (Reporting by Bhanvi Satija and Sneha SK in Bengaluru) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved